Propriété intellectuelle et santé publique
Brevets, innovation et accès
Des universitaires, les auteurs de rapports officiels et des usagers du système des brevets, y compris des chercheurs travaillant dans le domaine des vaccins et du traitement des maladies "négligées", ont posé une série de questions concernant l'efficacité et la pertinence des mesures incitatives qu'offre le système des brevets, ou les améliorations qu'elles pourraient nécessiter pour répondre aux besoins concernant les maladies qui touchent plus particulièrement les pays en développement. D'autres s'interrogent au sujet des effets des droits de propriété intellectuelle sur l'accès aux médicaments.
Documents
- Plus d'informations
-
Testimony of the Biotechnology Industry Organization on Competition and Intellectual Property Law and Policy in the Knowledge E-Based Economy Before the Federal Trade Commission and the Department of Justice | Competition Policy Center and the Berkeley Center for Law and Technology | University of California at Berkeley | 26 February 2002
-
Patents and Innovation: Trends and Policy Challenges | OECD | Paris, 2004
-
How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries? | By Amir Attaran | Health Affairs, Vol 23, Issue 3, 155-166 | May/ June 2004
-
A Patent System for the 21st Century | By S. A. Merill, R. C. Levin, M. B. Myers | Committee on Intellectual Property Rights in the Knowledge-Based Economy, Board on Science, Technology and Economic Policy | National Research Council | 2004
-
To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy | A Report by the Federal Trade Commission | October 2003
-
Keeping science open: the effects of intellectual property policy on the conduct of science | The Royal Society | 2003
-
Global Welfare in Pharmaceutical Patenting | F. M. Scherer | December 2003
-
Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India | By S. Chaudhuri, P. Goldberg, P. Jia, mimeo | December 2003
-
Integrating Intellectual Property Rights and Development Policy | UK Commission on Intellectual Property Rights | 2002
-
The Ethics of Patenting DNA: A Discussion Paper | Nuffield Council on Bioethics | 2002
-
Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment In Africa | By A. Attaran & L. Gillespie-White 2001 JAMA, vol. 286:15
-
Post- TRIPS options for access to patented medicines in developing Countries | F.M.Scherer & Jayashree Watal | CMH Working Paper 4:1 | January 2001
-
How Stronger Patent Protection in India Might Affect the Behavior of Transnational Pharmaceutical Industries | C. Fink | World Bank Working Paper No 2352 | 2000
-
Strengthening Protection of Intellectual Property in Developing Countries: A Survey of the Literature | Wolfgang E. Siebeck, editor, with Robert E. Evenson, William Lesser, and Carlos A. Primo Braga | 1990
-
A Better Way to Spur Medical Research and Development | By Rachel Glennerster and Michael Kremer
- IPR, Innovation, Human Rights and Access to Drugs [pdf 801kb]